{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "10230994", "DateCompleted": {"Year": "1999", "Month": "06", "Day": "15"}, "DateRevised": {"Year": "2017", "Month": "11", "Day": "16"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0891-9887", "JournalIssue": {"Volume": "11", "Issue": "4", "PubDate": {"Year": "1998", "Season": "Winter"}}, "Title": "Journal of geriatric psychiatry and neurology", "ISOAbbreviation": "J Geriatr Psychiatry Neurol"}, "ArticleTitle": "Complementary and alternative medicines for Alzheimer's disease.", "Pagination": {"StartPage": "163", "EndPage": "173", "MedlinePgn": "163-73"}, "Abstract": {"AbstractText": ["The recent successes of large, multicenter clinical trials of acetylcholinesterase inhibitors for symptomatic treatment of Alzheimer's disease have spawned enthusiasm that this common and fatal neurologic disease is \"treatable.\" A parallel explosion has occurred in the consumption of alternative medicines by the public seeking more effective, natural, or safer methods for treatment of dementia. Some of these medicines may, in fact, be biologically active in modulating the disease as well as producing side effects and interactions with accepted pharmaceuticals. This review brings to focus the scientific evidence presently available regarding such agents."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Memorial Hospital of Rhode Island, Brown University Department of Clinical Neurosciences, Pawtucket 02860, USA."}], "LastName": "Ott", "ForeName": "B R", "Initials": "BR"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Owens", "ForeName": "N J", "Initials": "NJ"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Geriatr Psychiatry Neurol", "NlmUniqueID": "8805645", "ISSNLinking": "0891-9887"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Dietary Fats"}, {"RegistryNumber": "0", "NameOfSubstance": "Hormones"}, {"RegistryNumber": "0", "NameOfSubstance": "Vitamins"}, {"RegistryNumber": "N91BDP6H0X", "NameOfSubstance": "Choline"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": ["therapy"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Choline"}, {"QualifierName": [], "DescriptorName": "Complementary Therapies"}, {"QualifierName": ["metabolism"], "DescriptorName": "Dietary Fats"}, {"QualifierName": [], "DescriptorName": "Dietary Supplements"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Ginkgo biloba"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Hormones"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Magnoliopsida"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["classification", "therapeutic use"], "DescriptorName": "Panax"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Vitamins"}, {"QualifierName": ["analysis"], "DescriptorName": "Wine"}], "NumberOfReferences": "117"}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1999", "Month": "5", "Day": "7"}, {"Year": "1999", "Month": "5", "Day": "7", "Hour": "0", "Minute": "1"}, {"Year": "1999", "Month": "5", "Day": "7", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10230994", "10.1177/089198879901100401"]}}]}